financetom
Business
financetom
/
Business
/
iRobot Shares Plunge As Preliminary Q4 Results Misses Mark—But CEO Bets Big On 2025 Comeback
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
iRobot Shares Plunge As Preliminary Q4 Results Misses Mark—But CEO Bets Big On 2025 Comeback
Jan 13, 2025 8:48 AM

Consumer robot maker iRobot Corp. ( IRBT ) shares are trading lower after the company revealed preliminary financial results for the fourth quarter, ending December 28, 2024.

Based on preliminary financial results, the company projects a revenue of approximately $171 million (consensus $187.84 million), alongside an expected GAAP operating loss of $59 million and a non-GAAP operating loss of $47 million.

iRobot had previously expected fourth-quarter revenue to be $175 million – $200 million with a GAAP operating loss of $43 million – $34 million and a non-GAAP operating loss of $31 million – $22 million.

“Our preliminary results reflect higher-than-anticipated seasonal promotional spending to stimulate sell-through prior to our 2025 new product launches,” said CEO Gary Cohen.

In addition, iRobot faced a $8 million non-recurring charge related to the write-off of excess component inventory and losses from non-cancelable purchase commitments.

These factors contributed to the company’s operating loss and affected its gross margin in the fourth quarter.

Despite the challenges, Cohen emphasized that the company is undergoing significant transformations in its product development process, which is expected to improve long-term financial performance.

He also highlighted the company’s efforts to streamline operations while investing in growth areas that will drive future success.

As of the close of FY24, iRobot anticipates holding $134 million in cash and equivalents, exceeding its internal forecasts.

Looking ahead, iRobot is optimistic about returning to year-over-year revenue growth in 2025 as it rolls out new and improved products.

The company predicts that the second half of 2025 will outperform the first, with stronger sales driven by an expanded product line. However, the first quarter of 2025 is expected to reflect ongoing transitions in its product offerings.

With reduced product costs and quicker development cycles, iRobot expects improved margins and profitability as the year progresses.

Price Action: IBRT shares are trading lower by 19.5% at $8.41 on the last check Monday.

Read Next:

Beer Maker Constellation Brands’ Q3 Sales Hit By Subdued Spending

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ESGold to Raise $5 Million in a Private Placement of Share Units
ESGold to Raise $5 Million in a Private Placement of Share Units
Sep 5, 2025
01:40 PM EDT, 09/05/2025 (MT Newswires) -- ESGold ( ESAUF ) on Friday on Friday said it will seek $5 million from a best-efforts private placement of share units, The company said it will place up to 6.7-million units with each priced at $0.75 and made up of a share and a three-year warrant to buy a second share for...
What's Going On With Nike Stock?
What's Going On With Nike Stock?
Sep 5, 2025
Nike Inc ( NKE ) shares are falling Friday in sympathy with Lululemon Athletica Inc ( LULU ) , as investors grew concerned that escalating U.S. tariffs on imported goods will pressure margins across the athletic apparel sector. What To Know: Lululemon stock tumbled 18% after the company slashed guidance, citing the removal of the de minimis exemption, which previously...
Kennedy and HHS to link Tylenol use in pregnancy to autism, WSJ reports
Kennedy and HHS to link Tylenol use in pregnancy to autism, WSJ reports
Sep 5, 2025
(Reuters) -U.S. Health Secretary Robert F. Kennedy Jr. plans to announce that use of Kenvue's popular over-the-counter pain medication Tylenol in pregnant women is potentially linked to autism, The Wall Street Journal reported on Friday, citing people familiar with the matter. Kennedy, in a report, will also suggest a medicine derived from folate called folinic acid can be used to...
US SEC announces task force to fight cross-border fraud
US SEC announces task force to fight cross-border fraud
Sep 5, 2025
WASHINGTON, Sept 5 (Reuters) - The Security and Exchange Commission said on Friday it will form a task force to fight cross-border fraud that hurts U.S. investors. The Cross-Border Task Force will focus initially on investigating potential U.S. federal securities law violations related to foreign-based companies, including potential market manipulation, such as 'pump-and-dump' and 'ramp-and-dump' schemes, the SEC said in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved